Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Holistic Sanctuary Empowers Patients to Permanently End Their Addiction to Suboxone and Other Opiates: All-Natural and Exclusive Solution
  • USA - English


News provided by

The Holistic Sanctuary

Oct 14, 2013, 13:50 ET

Share this article

Share toX

Share this article

Share toX

Vimeo
Vimeo

We permanently end these addictions – and we do so naturally, without any prescription medications, 12-step programs or attack therapy – because we seek to unify the mind, body and soul so people can have a second chance at life.

Post this

Los Angeles, CA (PRWEB) October 14, 2013 -- The Holistic Sanctuary announces its continued success in permanently healing patients with addictions to suboxone, subutex, buprenex, buprenorphine and other semi-synthetic opiates. This achievement is noteworthy because attempts to release generic versions of suboxone may worsen an already serious opiate epidemic. (1) Compounding these events is an overall addiction crisis – every 19 minutes, according to the Centers for Disease Control (CDC), there is an unintentional drug overdose death in the United States(2) – making addiction very difficult (for conventional drug rehab centers) to treat, never mind cure.

As for suboxone or buprenorphine, it so addictive, based on a study from the US National Library of Medicine National Institutes of Health, that it may fueling a new epidemic. (3) The study, which mirrors the private, independent research performed by The Holistic Sanctuary, reveals how dangerous – more threatening than heroin – suboxone is, leaving many people in a state of depression and dependent on more prescription medications, which further destroy a person’s immune system. The New York Times further exposes the global proportions of this crisis, "The Soaring Cost of the Opioid Economy," in which the paper states: "The number of prescriptions dispensed for two drugs increasingly given to treat opioid addiction — buprenorphine and naltrexone — has soared along with opioid use."(4)

More disturbing is the fact that the number of buprenorphine-related deaths may be vastly underreported. According to the Center for Substance Abuse Research, at the University of Maryland, at College Park: “The true magnitude and scope of buprenorphine diversion, misuse, and adverse consequences is unknown because current epidemiologic measures do not systematically monitor buprenorphine. Routine drug testing protocols used by workplaces and the criminal justice system may not include buprenorphine. Similarly, buprenorphine-related deaths are not accurately tracked because medical examiners and coroners do not routinely test for the drug.”(5)

Even the maker of suboxone acknowledges the threat of this drug, stating: “Suboxone can cause serious life-threatening respiratory depression and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other central nervous system (CNS) depressants.”(6)

Due to the severity of this epidemic and the high relapse rate among people addicted to suboxone, the success of The Holistic Sanctuary stands in marked contrast to the failures of other traditional forms of treatment. For example: McLean Hospital, a Harvard Medical School Affiliate, in conjunction with JAMA (The Journal of the American Medical Association) Psychiatry, finds that “monitored in four week increments, individuals showed an increasing rate of relapse the longer they remained off suboxone.”(7)

In addition, at a conventional drug treatment center, cravings will quickly begin 4 to 6 hours after the last dose of short-acting opioids, leading to active drug-seeking behavior. Anxiety, diaphoresis, and agitation begin after 8 to 12 hours and the other symptoms after 12 to 24 hours. Peak withdrawal discomfort usually occurs after 36 to 72 hours.(8)

For Johnny Tabaie, “Johnny The Healer,” (see also http://www.johnnythehealer.com/) the Founder of The Holistic Sanctuary, permanently ending addiction to suboxone is part of an advanced brain healing treatment, which puts an immediate stop to acute withdrawal symptoms and cravings. Through his safe, all-natural and effective solution, known as the Pouyan Method, Johnny corrects the root causes of all addictions by restoring and rejuvenating brain cells damaged from chemical abuse.

More importantly, he does not label – and he does not treat – addiction as an incurable disease. The ultimate proof of that point comes from the unsolicited video testimonials of guests, which are powerful, life-changing stories of people who experienced the physical, emotional and financial pain of conventional rehab, turning to The Holistic Sanctuary as their last means of hope.

“Addiction to suboxone is very difficult to treat because of the potency of this drug, which becomes even more dangerous when combined with a cocktail of other prescription medications. Patients then face two significant challenges, which conventional drug treatment centers overlook: The severity of suboxone itself, intensified by additional medicines for which there are no double-blind studies. Any one of these drugs has a long list of side effects, but together, the consequences can be many times more toxic, with complications such as: Liver damage, stroke, heart attack, renal failure, suicidal thoughts and death. We permanently end these addictions – and we do so naturally, without any prescription medications, 12-step programs or attack therapy – because we seek to unify the mind, body and soul so people can have a second chance at life,” says Mr. Tabaie.

As further proof of this exclusive brain healing treatment, prospective guests can see the indisputable evidence of The Holistic Sanctuary’s efforts involving the repair, restoration and rejuvenation of the areas damaged from addiction by clicking http://www.theholisticsanctuary.com

About The Holistic Sanctuary
The Holistic Sanctuary is the home of the exclusive, all-natural and proprietary Pouyan Method, which enables patients to permanently end a variety of addictions. Unlike conventional drug and alcohol rehabilitation centers, which have rates or failure or relapse among patients, The Holistic Sanctuary offers a customized protocol with the amenities of a 5-star resort. We seek to stop addiction without prescription medication or the use of 12-step programs. Nor do we classify patients as victims of an incurable disease. Our therapies focus on healing the brain, so a patient can heal their life. For more information about our innovative techniques, founding principles and testimonials from former patients, please visit http://www.theholisticsanctuary.com.

1. marketwatch.com/story/actavis-confirms-generic-suboxone-sublingual-film-patent-challenge-2013-10-08 ("Actavis Confirms Generic Suboxone® Sublingual Film Patent Challenge. MarketWatch; October 8, 2013)
2. cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm ("CDC Grand Rounds: Prescription Drug Overdoses — a U.S. Epidemic." Centers for Disease Control; January 13, 2012)
3. ncbi.nlm.nih.gov/pubmed/22356664 ("The emerging buprenorphine epidemic in the United States." US National Library of Medicine National Institutes of Health; January 31, 2012)
4. nytimes.com/interactive/2013/06/23/sunday-review/the-soaring-cost-of-the-opioid-economy.html ("The Soaring Cost of the Opioid Economy." The New York Times; June 22, 2013)
5. cesar.umd.edu/cesar/cesarfax/vol21/21-49.pdf ("Suboxone® Sales Estimated to Reach $1.4 Billion in 2012—More Than Viagra® or Adderall®." The Center for Substance Abuse Research; December 10, 2012)
6. suboxone.com/patients/safety/Default.aspx ("Important Safety Information." Reckitt Benckiser Pharmaceuticals Inc.; October 14, 2013)
7. archpsyc.jamanetwork.com/article.aspx?articleid=1107433 ("Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence." JAMA Psychiatry; December 2011)
8. cfp.ca/content/58/1/37.full ("Update on the clinical use of buprenorphine
In opioid-related disorders." Canadian Family Physician; January 2012)

Johnny Tabaie, The Holistic Sanctuary, http://www.theholisticsanctuary.com, +1 3236069904, [email protected]

Modal title

Addiction Cure Center Paradise
Addiction Cure Center Paradise
5 Star Healing Addiction Center
5 Star Healing Addiction Center
Natural High, Weekend Excursions
Natural High, Weekend Excursions
Healthy Organic Healing SuperFoods
Healthy Organic Healing SuperFoods
The Holistic Sanctuary
The Holistic Sanctuary
Addiction Cure Center Paradise 5 Star Healing Addiction Center Natural High, Weekend Excursions Healthy Organic Healing SuperFoods The Holistic Sanctuary

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.